Breaking News Instant updates and real-time market news.

TEVA

Teva

$23.29

-0.45 (-1.90%)

, NVS

Novartis

$78.78

-0.15 (-0.19%)

17:47
07/13/18
07/13
17:47
07/13/18
17:47

FDA announces voluntary recall of several medicines containing valsartan

The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan, used to treat high blood pressure and heart failure. This recall is due to an impurity, N-nitrosodimethylamine, which was found in the recalled products. However, not all products containing valsartan are being recalled. NDMA is classified as a probable human carcinogen based on results from laboratory tests. The presence of NDMA was unexpected and is thought to be related to changes in the way the active substance was manufactured. The FDA's review is ongoing and has included investigating the levels of NDMA in the recalled products, assessing the possible effect on patients who have been taking them and what measures can be taken to reduce or eliminate the impurity from future batches produced by the company. Reference Link

TEVA

Teva

$23.29

-0.45 (-1.90%)

NVS

Novartis

$78.78

-0.15 (-0.19%)

  • 10

    Sep

  • 16

    Sep

TEVA Teva
$23.29

-0.45 (-1.90%)

06/25/18
GSCO
06/25/18
NO CHANGE
Target $28
GSCO
Buy
Teva price target raised to $28 from $25 at Goldman Sachs
Goldman analyst Jami Rubin raised Buy rated Teva's price target to $28 from $25 following meetings with management last week. The analyst said there has been a "stark shift" by interim management from being fairly reactionary and directionless to now being a company led by leaders who are "action-oriented" with a rapid and clear path to recovery. Rubin said the discussions focused on progress on price cuts, deleveraging, stabilization of the US generics business, specialty opportunities, and the next chapter of growth expected in 2020. The analyst believes guidance is likely to be revised higher as Copaxone has show to be more durable despite generic competition and US generics have stabilized and guidance still assumes ProAir competition this year. Further, Rubin sees upside potential from Austedo and Fremanezumab that could drive EBITDA upside and cash flow for faster debt repayment.
06/27/18
SBSH
06/27/18
NO CHANGE
SBSH
Buy
Teva added to CIti's US Focus List with 'favorable' risk-reward profile
Citi analyst Liav Abraham added Teva to his US Focus List, telling investors in a research note that he continues to see a "favorable" risk-reward profile and that the stock benefits from the most clear and material upside to estimates among the stocks in his coverage universe. He views earnings upside as the most material driver of stock price performance for the specialty pharma sector over the near to medium term, "especially against a backdrop of fundamentals that appear to have stabilized." Looking ahead, Abraham sees a guidance raise along with Q2 earnings.
07/12/18
GSCO
07/12/18
DOWNGRADE
Target $74
GSCO
Sell
Perrigo downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Jami Rubin downgraded Perrigo (PRGO) to Sell and lowered her price target for the shares to $74 from $78. The analyst sees "no meaningful risk" to estimates but expects the "business to drift" due to a lack of meaningful new launches in the pipeline. The market may also attribute a lower multiple to Perrigo's consumer business as rates rise, which creates downside risk to the equity, Rubin tells investors in a research note. She sees more upside in other stocks, namely Mylan (MYL) and Teva (TEVA).
07/13/18
EVER
07/13/18
NO CHANGE
EVER
In Line
Evercore says FDA tentatively approves generic of another top 10 Valeant drug
Evercore ISI analyst Umer Raffat notes that the FDA website shows that a generic version of Valeant's (VRX) Apriso, a top 10 product for the company, has been granted a tentative approval. This approval, which was granted to Teva (TEVA), is the second generic approval for one of the company's top 10 products in the last few days, as a generic Uceris approval was also recently granted, added Raffat in his note to investors. He maintains an In Line rating on Valeant shares.
NVS Novartis
$78.78

-0.15 (-0.19%)

07/02/18
HCWC
07/02/18
NO CHANGE
Target $10
HCWC
Buy
Adamis price target raised to $10 from $7 at H.C. Wainwright
H.C. Wainwright analyst Jason Kolbert raised his price target for Adamis Pharmaceuticals (ADMP) to $10 after the company announced that Novartis (NVS) division Sandoz division will commercialize Symjepi. While the deal took longer than expected, the terms of a 50:50 split is better than anticipated, Kolbert tells investors in a research note. The analyst sees Sandoz as a "great partner" and reiterates a Buy rating on Adamis.
07/02/18
ROTH
07/02/18
NO CHANGE
Target $22
ROTH
Buy
Cryoport price target raised to $22 from $12.50 at Roth Capital
Roth Capital analyst Richard Baldry raised his price target for Cryoport (CYRX) to $22 from $12.50 while reiterating a Buy rating on the shares. The analyst notes that the European Medicines Agency recommended "marketing authorizations" for therapies developed by two of Cryoport's clients, Gilead's (GILD) Yescarta and Novartis' (NVS) Kymriah. Baldry believes these two approvals roughly double the addressable market for the therapies and offer upside potential to our 2019 forecasts.
07/11/18
WELS
07/11/18
NO CHANGE
WELS
Drug stocks may not react favorably to Pfizer price rollback, Trump tweets, says Wells Fargo
Wells Fargo analyst David Maris notes that there was widespread media coverage of drug price increases taken recently by several large cap drug companies, with President Trump criticizing Pfizer (PFE) for taking these price increases. On Tuesday, Pfizer confirmed it was rolling back its July drug price increases following a conversation with President Trump, he adds. Maris believes that drug stocks will not react favorably to this news, given the chilling effect this will likely have on others looking to take price increases. Nonetheless, the analyst points out that the price increases taken in July are only a small number of increases taken over the past year or several years, so the impact of the rollback to the healthcare system is insignificant in the big picture. Other publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Roche (RHHBY) and Sanofi (SNY).
07/12/18
PIPR
07/12/18
NO CHANGE
Target $95
PIPR
Neutral
PTAB decision on Gilenya positive for Celgene, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond expects the market to react positively with respect to Celgene (CELG) shares, at least initially, following the Patent Trial and Appeal Board decision regarding ozanimod competitor Gilenya from Novartis (NVS). Yesterday, the PTAB issued a decision that upholds validity of Gilenya's dosing patent in response to inter partes review petitions from multiple generic filers, Raymond tells investors in a research note. While this decision will likely be appealed, it opens up the possibility for Gilenya intellectual property runway out to 2027, when the dosing patent expire, the analyst adds. Raymond believes that not having a generic S1P class at launch for ozanimod is positive for Celgene. However, without the removal of first dose monitoring, ozanimod is not likely to be differentiated enough to make a difference, the analyst says, citing physician feedback. He keeps a Neutral rating on Celgene with a $95 price target. The stock in early trading is up 2% to $84.92.

TODAY'S FREE FLY STORIES

03:05
07/23/18
07/23
03:05
07/23/18
03:05
General news
FX Update: The dollar remained on a softening track »

FX Update: The dollar…

AGIO

Agios Pharmaceuticals

$91.06

-0.23 (-0.25%)

, CELG

Celgene

$85.09

-0.26 (-0.30%)

20:07
07/22/18
07/22
20:07
07/22/18
20:07
Recommendations
Agios Pharmaceuticals, Celgene analyst commentary at Piper Jaffray »

Agios' Tibsovo…

AGIO

Agios Pharmaceuticals

$91.06

-0.23 (-0.25%)

CELG

Celgene

$85.09

-0.26 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 21

    Aug

SYNT

Syntel

$39.15

0.14 (0.36%)

, FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

19:25
07/22/18
07/22
19:25
07/22/18
19:25
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

SYNT

Syntel

$39.15

0.14 (0.36%)

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

PM

Philip Morris

$84.31

3.41 (4.22%)

RACE

Ferrari

$139.98

-2.65 (-1.86%)

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

NFLX

Netflix

$361.33

-2.81 (-0.77%)

TSLA

Tesla

$313.49

-6.85 (-2.14%)

SNE

Sony

$52.97

0.355 (0.67%)

AB

AllianceBernstein

$29.90

-0.05 (-0.17%)

BLK

BlackRock

$503.01

-1.42 (-0.28%)

BEN

Franklin Resources

$31.99

-0.28 (-0.87%)

IVZ

Invesco

$25.46

-0.245 (-0.95%)

LM

Legg Mason

$33.37

-0.13 (-0.39%)

TROW

T. Rowe Price

$119.87

-0.85 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 01

    Aug

  • 01

    Aug

  • 06

    Aug

  • 07

    Aug

  • 15

    Aug

  • 16

    Aug

  • 16

    Aug

INDB

Independent Bank

$88.10

6.45 (7.90%)

17:48
07/22/18
07/22
17:48
07/22/18
17:48
Upgrade
Independent Bank rating change at Keefe Bruyette »

Independent Bank upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHLB

Berkshire Hills Bancorp

$41.40

0.45 (1.10%)

17:47
07/22/18
07/22
17:47
07/22/18
17:47
Downgrade
Berkshire Hills Bancorp rating change at Keefe Bruyette »

Berkshire Hills…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Acquired by T

$0.00

(0.00%)

, CMCSA

Comcast

$34.30

-0.61 (-1.75%)

17:14
07/22/18
07/22
17:14
07/22/18
17:14
Hot Stocks
Box Office Battle: 'Equalizer 2' beats 'Mamma Mia: Here We Go Again!' »

Sony's (SNE)…

TWX

Acquired by T

$0.00

(0.00%)

CMCSA

Comcast

$34.30

-0.61 (-1.75%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$52.97

0.355 (0.67%)

FOX

21st Century Fox

$45.69

-0.5 (-1.08%)

FOXA

21st Century Fox

$46.01

-0.54 (-1.16%)

LGF.A

Lionsgate

$24.88

-0.08 (-0.32%)

DIS

Disney

$111.48

-0.66 (-0.59%)

VIAB

Viacom

$27.49

-0.51 (-1.82%)

VIA

Viacom

$32.10

-0.3 (-0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 27

    Jul

  • 07

    Aug

  • 09

    Aug

  • 09

    Aug

  • 09

    Aug

BGNE

BeiGene

$169.98

5.95 (3.63%)

16:43
07/22/18
07/22
16:43
07/22/18
16:43
Hot Stocks
BeiGene planning to pursue accelerated approval in U.S. of Zanubrutinib in WM »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$169.98

5.95 (3.63%)

16:40
07/22/18
07/22
16:40
07/22/18
16:40
Hot Stocks
BeiGene announces preliminary topline results of Hodgkin's Lymphoma trial »

BeiGene announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNT

Syntel

$39.15

0.14 (0.36%)

16:17
07/22/18
07/22
16:17
07/22/18
16:17
Earnings
Syntel reports preliminary Q2 EPS 49c, consensus 44c »

Reports preliminary Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 06

    Aug

  • 15

    Aug

  • 16

    Aug

SYNT

Syntel

$39.15

0.14 (0.36%)

16:13
07/22/18
07/22
16:13
07/22/18
16:13
Hot Stocks
Syntel enters definitive agreement to be acquired by Atos S.E. »

Syntel announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 06

    Aug

  • 15

    Aug

  • 16

    Aug

DDE

Dover Downs

$2.04

0.01 (0.49%)

16:11
07/22/18
07/22
16:11
07/22/18
16:11
Hot Stocks
Dover Downs to combine with Twin River Worldwide »

Dover Downs and Twin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWO

Two Harbors

$15.92

-0.05 (-0.31%)

, CYS

CYS Investments

$7.57

-0.025 (-0.33%)

13:36
07/22/18
07/22
13:36
07/22/18
13:36
Conference/Events
CYS Investments to host special shareholder meeting »

Special Shareholder…

TWO

Two Harbors

$15.92

-0.05 (-0.31%)

CYS

CYS Investments

$7.57

-0.025 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 08

    Aug

CYS

CYS Investments

$7.57

-0.025 (-0.33%)

, TWO

Two Harbors

$15.92

-0.05 (-0.31%)

13:34
07/22/18
07/22
13:34
07/22/18
13:34
Conference/Events
Two Harbors to host special shareholder meeting »

Special Shareholder…

CYS

CYS Investments

$7.57

-0.025 (-0.33%)

TWO

Two Harbors

$15.92

-0.05 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

JD

JD.com

$35.50

-1.37 (-3.72%)

13:28
07/22/18
07/22
13:28
07/22/18
13:28
Periodicals
JD.com plans move into Europe, Reuters reports »

JD.com's chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$191.29

-0.66 (-0.34%)

12:37
07/22/18
07/22
12:37
07/22/18
12:37
Periodicals
China aiming to supply Apple with OLED smartphone screens, WSJ says »

China's campaign to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

PZZA

Papa John's

$51.61

0.62 (1.22%)

12:30
07/22/18
07/22
12:30
07/22/18
12:30
Periodicals
Papa John's board to discuss 'poison pill,' WSJ reports »

Papa John's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$0.00

(0.00%)

, BAESY

BAE Systems

$0.00

(0.00%)

12:22
07/22/18
07/22
12:22
07/22/18
12:22
Periodicals
Airbus CEO says open to jet fighter merger with BAE Systems, Reuters reports »

The chief executive of…

EADSY

Airbus

$0.00

(0.00%)

BAESY

BAE Systems

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

12:17
07/22/18
07/22
12:17
07/22/18
12:17
Periodicals
Volkswagen parking cars due to new emissions testing bottlenecks, Reuters says »

Volkswagen is renting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$27.26

0.21 (0.78%)

12:11
07/22/18
07/22
12:11
07/22/18
12:11
Hot Stocks
KKR consortium proposes acquisition of LCY Chemical »

LCY Chemical and global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

PM

Philip Morris

$84.31

3.41 (4.22%)

, RACE

Ferrari

$139.98

-2.65 (-1.86%)

11:58
07/22/18
07/22
11:58
07/22/18
11:58
Hot Stocks
Philip Morris' non-executive board chairman to assume CEO role at Ferrari »

Philip Morris (PM) said…

PM

Philip Morris

$84.31

3.41 (4.22%)

RACE

Ferrari

$139.98

-2.65 (-1.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

MDLZ

Mondelez

$42.46

0.21 (0.50%)

11:55
07/22/18
07/22
11:55
07/22/18
11:55
Hot Stocks
Mondelez conducts voluntary recall of certain Ritz Cracker sandwiches »

Mondelez Global announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

ACN

Accenture

$166.47

-0.47 (-0.28%)

, EADSY

Airbus

$0.00

(0.00%)

04:55
07/22/18
07/22
04:55
07/22/18
04:55
Conference/Events
Farnborough International to hold an airshow »

Farnborough International…

ACN

Accenture

$166.47

-0.47 (-0.28%)

EADSY

Airbus

$0.00

(0.00%)

ATI

Allegheny Technologies

$26.65

0.08 (0.30%)

BAESY

BAE Systems

$0.00

(0.00%)

BDRBF

Bombardier

$0.00

(0.00%)

CAE

CAE

$20.96

0.17 (0.82%)

CW

Curtiss-Wright

$125.79

-0.12 (-0.10%)

DASTY

Dassault Systemes

$0.00

(0.00%)

ESLT

Elbit Systems

$118.98

0.64 (0.54%)

LMT

Lockheed Martin

$322.76

3.09 (0.97%)

BA

Boeing

$354.92

-0.57 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 24

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 02

    Aug

  • 06

    Aug

  • 16

    Aug

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

13:14
07/21/18
07/21
13:14
07/21/18
13:14
Hot Stocks
Fiat names Jeep head as CEO as Marchionne's health worsens »

In a statement, Fiat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RACE

Ferrari

$139.98

-2.65 (-1.86%)

, PM

Philip Morris

$84.31

3.41 (4.22%)

13:10
07/21/18
07/21
13:10
07/21/18
13:10
Hot Stocks
Ferrari to name former Philip Morris chairman as CEO »

The Board of Directors of…

RACE

Ferrari

$139.98

-2.65 (-1.86%)

PM

Philip Morris

$84.31

3.41 (4.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

, TM

Toyota

$131.87

0.11 (0.08%)

12:51
07/21/18
07/21
12:51
07/21/18
12:51
Periodicals
Amazon, others working to counter Trump's tariff plans, Reuters says »

Big companies in the…

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

TM

Toyota

$131.87

0.11 (0.08%)

AA

Alcoa

$40.32

-1.36 (-3.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 16

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.